ARCHIVES

Funding Opportunities: RFA Available: Teams For Molecular Target Assessment

This article is from The Cancer Letter archive.

Vol. 25 No. 45 | November 26, 1999

Download PDF Visit The Full Archive

Related Articles

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

Reader Finds Letter insulting to Ethic Group

February 16, 1996

In Brief: Budget Resolution Calls For 1% Cut In NIH, Then Six Years At 3% Below Current Budget

July 7, 1995

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Congressman Obey Attacks NCI for Not Supporting Basic Research

January 23, 1976

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987